Skip to main content

Select Drug Profiles

In the News
Management of the Multiple Sclerosis Category: An Increasing Focus for Payers
Read More
In the News
Achieving Consensus between Healthcare Providers and Payers
Read More
In the News
Treating Multiple Sclerosis: The Healthcare Provider Perspective
Read More
In the News
Management of Multiple Sclerosis: Building Consensus between Healthcare Providers and Payers Overview
John A. Welz, MPH
Read More
In the News
Multiple Sclerosis Disease State Review
Read More
Perspectives
Interesting Times Ahead: Payers’ Innovation in the Era of Healthcare Reform
Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Perspectives
The Use of Medicines in the United States: A Detailed Review
David B. Nash, MD, MBA
Read More
Practice Management
Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets
Anke-Peggy Holtorf, PhD, MBA, Diana Brixner, RPh, PhD, Brandon Bellows, PharmD, Abdulkadir Keskinaslan, MD, MBA, MPH, Joseph Dye, RPh, PhD, Gary Oderda, PharmD, MPH
Stakeholder Perspective
Health Economics and Outcomes Research Data Key in Coverage Decisions of New Medications
by Douglas S. Burgoyne, PharmD, FAMCP
Read More
Practice Management
The Policy-Driven Health Plan: A Road Map for Value-Based Reimbursement
James Evans
Read More
Practice Management
Hematologic Complications, Healthcare Utilization, and Costs in Commercially Insured Patients with Myelodysplastic Syndrome Receiving Supportive Care
Annette Powers, PharmD, MBA, Claudio Faria, PharmD, MPH, Eunice Chang, PhD, Dasha Cherepanov, PhD, Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Reconsidering the Management of Younger Patients with Myelodysplastic Syndrome
Read More
Page 189 of 244
Results 1881 - 1890 of 2434